Re: Efficacy and Toxicity of Sunitinib in Patients With Metastatic Renal Cell Carcinoma With Severe Renal Impairment or in Haemodialysis Editorial Comment

被引：0
|
作者：
Taneja, Samir S.
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.12.129
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1223 / 1224
页数：2
相关论文
共 50 条
  • [31] Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma Patients
    Zama, Ivan N.
    Hutson, Thomas E.
    Elson, Paul
    Cleary, James M.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    Ramaiya, Nikhil
    Michaelson, M. Dror
    Garcia, Jorge A.
    Knox, Jennifer J.
    Escudier, Bernard
    Rini, Brian I.
    CANCER, 2010, 116 (23) : 5400 - 5406
  • [32] Sunitinib for metastatic renal cell carcinoma
    Mukherji, Deborah
    Larkin, James
    Pickering, Lisa
    FUTURE ONCOLOGY, 2010, 6 (09) : 1377 - 1385
  • [33] Biological toxicity as a predictive factor of efficacy in metastatic renal cell carcinoma (mRCC) treated with sunitinib
    Guillabert, P.
    Elaidi, R. T.
    Teghom, C.
    Medioni, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S651 - S651
  • [34] Metastatic Renal Cell Cancer Treated With Sunitinib - Toxicity and Efficacy in the Elderly
    Couto, N.
    Sousa, N.
    Begonha, R.
    Oliveira, J.
    Mauricio, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S278 - S278
  • [35] GENETIC POLYMORPHISMS AND SUNITINIB TOXICITY IN METASTATIC RENAL-CELL CARCINOMA
    Sepulveda Sanchez, J.
    Farfan, C.
    Villacampa, F.
    Velasco, G.
    Benitez, J.
    Rodriguez, C.
    Calderon, M.
    Canamares, I.
    Cortes-Funes, H.
    Castellano, D. E.
    ANNALS OF ONCOLOGY, 2012, 23 : 281 - 282
  • [36] Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma Editorial Comment
    Marshall, Fray F.
    JOURNAL OF UROLOGY, 2010, 183 (03): : 937 - 938
  • [37] Re: Pazopanib Versus Sunitinib in Metastatic Renal-cell Carcinoma
    Sun, Maxine
    Quoc-Dien Trinh
    Perrotte, Paul
    Karakiewicz, Pierre I.
    EUROPEAN UROLOGY, 2014, 65 (05) : 1014 - 1015
  • [38] Re: Pazopanib Versus Sunitinib in Metastatic Renal-cell Carcinoma
    Ouzaid, Idir
    Rini, Brian
    EUROPEAN UROLOGY, 2014, 65 (03) : 667 - 668
  • [39] Re: A Phase 2 Trial of Sunitinib in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2012, 188 (06): : 2146 - 2147
  • [40] ESTIMATED GFR AS A BIOMARKER OF EFFICACY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUNITINIB
    Kato, Tomoyuki
    Bilim, Vladimir
    Nakayama, Shoko
    Narisawa, Takafumi
    Yamagishi, Atsushi
    Sakurai, Toshihiko
    Nishida, Hayato
    Naito, Sei
    Kawazoe, Hisashi
    Ichiyanagi, Osamu
    Nagaoka, Akira
    Tomita, Yoshihiko
    JOURNAL OF UROLOGY, 2012, 187 (04): : E810 - E810
12345